XINYUAN HU: Open Payments
NPI 1508522426 · CITY OF INDUSTRY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,869 in 113 payments from 14 companies in 2025. Trend: 2023 $2,170 · 2024 $1,411 · 2025 $2,869
Food & beverage: $2,680Education: $189
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $469 |
| Galderma Laboratories, L.P. | 14 | $428 |
| Incyte Corporation | 21 | $404 |
| ABBVIE INC. | 20 | $403 |
| Janssen Biotech, Inc. | 14 | $329 |
| Organon LLC | 5 | $195 |
| Amgen Inc. | 10 | $195 |
| Regeneron Healthcare Solutions, Inc. | 3 | $109 |
| Arcutis Biotherapeutics, Inc. | 3 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $89 |
Products named: DUPIXENT, OPZELURA, NEMLUVIO, SKYRIZI, TREMFYA, OTEZLA, VTAMA, Zoryve.
Industry payments across CA — which companies pay providers there.
